Assessment of intravitreal anti-VEGF drugs and dexamethasone for retinal diseases in real world setting: A multi-centre prospective study from Southern Italy
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Ophthalmology"
DOI: 10.1177/11206721211073402
Abstract: Describe drug utilisation and clinical outcomes of intravitreal anti-VEGF drug and dexamethasone use in the real-world setting in Southern Italy using data from multi-centre study of retinal disease. Clinical data of retinal disease patients treated… read more here.
Keywords: ophthalmology; anti vegf; vegf drugs; intravitreal anti ... See more keywords
Use Of Anti-Vegf Drugs In Retinal Vein Occlusions.
Sign Up to like & getrecommendations! Published in 2020 at "Current drug targets"
DOI: 10.2174/1389450121666200428101343
Abstract: Retinal vein occlusion (RVO) is one of the most prevalent causes of visual loss in the Western World. Its pathogenesis is still not completely known. Chronic macular edema and ischemia compromise the functional and anatomical… read more here.
Keywords: anti vegf; retinal vein; vegf drugs; use anti ... See more keywords
Intravitreal Anti-VEGF Drugs and Signals of Dementia and Parkinson-Like Events: Analysis of the VigiBase Database of Spontaneous Reports
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2020.00315
Abstract: Introduction Since vascular endothelial growth factor (VEGF) regulates several aspects of the central nervous system, particularly in dopaminergic neurons, VEGF inhibitors may be linked to Parkinson-like events and dementia, or variants of these diseases. Two… read more here.
Keywords: anti vegf; like events; intravitreal anti; parkinson ... See more keywords
Anti-VEGF Drugs Dynamics: Relevance for Clinical Practice
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14020265
Abstract: Background: A drug and disease assessment model was used to evaluate the impact of different treatment regimens on intravitreal ranibizumab, bevacizumab, aflibercept, and brolucizumab concentrations and the proportion of free vascular endothelial growth factor (VEGF)… read more here.
Keywords: ranibizumab bevacizumab; proportion; vegf; anti vegf ... See more keywords
Early biomarkers of nephrotoxicity associated with the use of anti-VEGF drugs.
Sign Up to like & getrecommendations! Published in 2022 at "Biomedical reports"
DOI: 10.3892/br.2022.1529
Abstract: Anti-angiogenic anticancer drugs that block vascular endothelial growth factor (VEGF) can cause kidney damage. An early assessment of the risk of nephrotoxicity would allow the development of optimal treatment approaches and allow for relatively safer… read more here.
Keywords: early biomarkers; vegf; anti vegf; hif ... See more keywords